| Basics |
LivaNova PLC Ordinary Shares
LivaNova PLC is a medical technology company formed by the merger of Sorin S.p.A, engaged in the treatment of cardiovascular diseases, and Cyberonics Inc., a medical device company with core expertise in neuromodulation.
|
| IPO Date: |
October 19, 2015 |
| Sector: |
Healthcare |
| Industry: |
Medical Devices |
| Market Cap: |
$2.4B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.95 | 1.47%
|
| Avg Daily Range (30 D): |
$0.53 | 1.31%
|
| Avg Daily Range (90 D): |
$0.69 | 1.67%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.4M |
| Avg Daily Volume (30 D): |
.7M |
| Avg Daily Volume (90 D): |
.63M |
| Trade Size |
| Avg Trade Size (Sh.): |
68 |
| Avg Trade Size (Sh.) (30 D): |
50 |
| Avg Trade Size (Sh.) (90 D): |
49 |
| Institutional Trades |
| Total Inst.Trades: |
6,268 |
| Avg Inst. Trade: |
$2.45M |
| Avg Inst. Trade (30 D): |
$2.13M |
| Avg Inst. Trade (90 D): |
$2.15M |
| Avg Inst. Trade Volume: |
.04M |
| Avg Inst. Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$3.22M |
| Avg Closing Trade (30 D): |
$3.95M |
| Avg Closing Trade (90 D): |
$3.78M |
| Avg Closing Volume: |
51.94K |
|
|
|
|
| Financials |
| |
TTM |
Q4 2024 |
FY 2024 |
|
Basic EPS
|
$-6.01
|
$1.03
|
$1.17
|
|
Diluted EPS
|
$-6.01
|
$1.03
|
$1.16
|
|
Revenue
|
$ 316.86M
|
$ 321.83M
|
$ 1.25B
|
|
Gross Profit
|
$ 220.78M
|
$ 219.35M
|
$ 870.87M
|
|
Net Income / Loss
|
$ -327.32M
|
$ 55.89M
|
$ 63.23M
|
|
Operating Income / Loss
|
$ 48.62M
|
$ 37.02M
|
$ 129.05M
|
|
Cost of Revenue
|
$ 96.08M
|
$ 102.48M
|
$ 382.56M
|
|
Net Cash Flow
|
$ 14.88M
|
$ 56.98M
|
$ 145.68M
|
|
PE Ratio
|
|
|
|
|
